Home » Stocks » FGEN

FibroGen, Inc. (FGEN)

Stock Price: $20.23 USD -0.41 (-1.99%)
Updated May 7, 2021 4:00 PM EDT - Market closed
After-hours: $20.25 +0.02 (0.10%) May 7, 7:51 PM
Market Cap 1.86B
Revenue (ttm) 176.32M
Net Income (ttm) -189.29M
Shares Out 89.85M
EPS (ttm) -2.11
PE Ratio n/a
Forward PE 61.35
Dividend n/a
Dividend Yield n/a
Trading Day May 7
Last Price $20.23
Previous Close $20.64
Change ($) -0.41
Change (%) -1.99%
Day's Open 20.85
Day's Range 20.10 - 21.22
Day's Volume 686,958
52-Week Range 18.12 - 57.21

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Boston, Massachusetts--(Newsfile Corp. - May 8, 2021) - The Thornton Law Firm alerts investors that a class action lawsuit has been filed on behalf of investors of FibroGen, Inc. (NASDAQ: FGEN). The cas...

4 hours ago - Newsfile Corp

San Francisco, California--(Newsfile Corp. - May 7, 2021) -  Hagens Berman urges FibroGen, Inc. (NASDAQ: FGEN) investors with significant losses to submit your losses now.Class Period: Oct. 18, 2017 - A...

20 hours ago - Newsfile Corp

San Francisco, California--(Newsfile Corp. - May 7, 2021) -  On April 12, 2021, Berman Tabacco filed a class action lawsuit for violations of the federal securities laws against FibroGen, Inc. ("FibroGe...

22 hours ago - Newsfile Corp

FibroGen (FGEN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

1 day ago - Zacks Investment Research

New Orleans, Louisiana--(Newsfile Corp. - May 6, 2021) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until...

1 day ago - Newsfile Corp

NEW YORK, May 6, 2021 /PRNewswire/ -- Today, prominent investor rights law firm Bernstein Litowitz Berger & Grossmann LLP ("BLB&G") filed a class action lawsuit for violations of the federal securities ...

1 day ago - PRNewsWire

Los Angeles, California--(Newsfile Corp. - May 6, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against FibroGen, Inc. ("FibroGe...

2 days ago - Newsfile Corp

Radnor, Pennsylvania--(Newsfile Corp. - May 6, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that a securities fraud class action lawsuit has been filed against FibroGen, ...

2 days ago - Newsfile Corp

Boston, Massachusetts--(Newsfile Corp. - May 6, 2021) - The Thornton Law Firm alerts investors that a class action lawsuit has been filed on behalf of investors of FibroGen, Inc. (NASDAQ: FGEN). The cas...

2 days ago - Newsfile Corp

New York, New York--(Newsfile Corp. - May 6, 2021) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of FibroGen, Inc..Shareholders who pur...

2 days ago - Newsfile Corp

New York, New York--(Newsfile Corp. - May 5, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of FibroGen, Inc. (NASDAQ: FGEN) between November 8, 201...

2 days ago - Newsfile Corp

New York, New York--(Newsfile Corp. - May 5, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased FibroGen, Inc. ("Fibro...

2 days ago - Newsfile Corp

RADNOR, Pa., May 5, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that a securities fraud class action lawsuit has been filed against FibroGen, Inc. (NASDAQ: ...

3 days ago - PRNewsWire

New York, New York--(Newsfile Corp. - May 5, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of FibroG...

3 days ago - Newsfile Corp

New York, New York--(Newsfile Corp. - May 5, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against FibroGen, Inc. ("FibroGen" or the "Company") (NASDAQ: FGEN) and certain of...

3 days ago - Newsfile Corp

LOS ANGELES, May 5, 2021 /PRNewswire/ --  Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming  June 11, 2021  deadline to file a lead plaintiff motion in the class action filed on beha...

3 days ago - PRNewsWire

Los Angeles, California--(Newsfile Corp. - May 5, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against FibroGen, Inc. ("FibroGe...

3 days ago - Newsfile Corp

New York, New York--(Newsfile Corp. - May 5, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of FibroGen, Inc. (NASDAQ: FGEN) alleging that th...

3 days ago - Newsfile Corp

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In FibroGen To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Cor...

3 days ago - Newsfile Corp

Radnor, Pennsylvania--(Newsfile Corp. - May 4, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors of FibroGen, Inc. (NASDAQ: FGEN) ("FibroGen") that a securities fraud class ac...

3 days ago - Newsfile Corp

New York, New York--(Newsfile Corp. - May 4, 2021) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of FibroGen, Inc.Shareholders who purc...

3 days ago - Newsfile Corp

Los Angeles, California--(Newsfile Corp. - May 4, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against FibroGen, Inc. ("FibroGe...

4 days ago - Newsfile Corp

New York, New York--(Newsfile Corp. - May 3, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased FibroGen, Inc. ("Fibro...

4 days ago - Newsfile Corp

Boston, Massachusetts--(Newsfile Corp. - May 3, 2021) - Block & Leviton LLP (www.blockleviton.com), a national securities litigation firm, announces that a lawsuit for violations of the federal securiti...

4 days ago - Newsfile Corp

Los Angeles, California--(Newsfile Corp. - May 3, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against FibroGen, Inc. ("FibroGe...

5 days ago - Newsfile Corp

NEW YORK, May 1, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against FibroGen, Inc. ("FibroGen" or the "Company") (NASDAQ: FGEN) and certain of its officers. ...

6 days ago - PRNewsWire

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In FibroGen To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Cor...

1 week ago - Newsfile Corp

RADNOR, Pa., April 30, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors of FibroGen, Inc. (NASDAQ: FGEN) ("FibroGen") that a securities fraud class action lawsui...

1 week ago - PRNewsWire

Los Angeles, California--(Newsfile Corp. - April 30, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against FibroGen, Inc. ("Fibr...

1 week ago - Newsfile Corp

New York, New York--(Newsfile Corp. - April 30, 2021) - Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securi...

1 week ago - Newsfile Corp

SAN FRANCISCO--(BUSINESS WIRE)-- #Fibrogen--FIBROGEN SHAREHOLDERS: June 11, 2021 Filing Deadline in Class Action – Contact Lieff Cabraser

1 week ago - Business Wire

New Orleans, Louisiana--(Newsfile Corp. - April 29, 2021) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have un...

1 week ago - Newsfile Corp

FibroGen (FGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 week ago - Zacks Investment Research

San Francisco, California--(Newsfile Corp. - April 29, 2021) - Hagens Berman urges FibroGen, Inc. (NASDAQ: FGEN) investors with significant losses to submit your losses now. Class Period: Nov. 8, 2019 -...

1 week ago - Newsfile Corp

New York, New York--(Newsfile Corp. - April 29, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Fib...

1 week ago - Newsfile Corp

Los Angeles, California--(Newsfile Corp. - April 29, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against FibroGen, Inc. (NASDA...

1 week ago - Newsfile Corp

Philadelphia, Pennsylvania--(Newsfile Corp. - April 29, 2021) - Berger Montague is investigating potential securities fraud claims against FibroGen, Inc. ("FibroGen" or the "Company") on behalf of inves...

1 week ago - Newsfile Corp

New York, New York--(Newsfile Corp. - April 28, 2021) - Pomerantz LLP is investigating claims on behalf of investors of FibroGen, Inc. ("FibroGen" or the "Company")(NASDAQ: FGEN). Such investors are adv...

1 week ago - Newsfile Corp

Radnor, Pennsylvania--(Newsfile Corp. - April 28, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that a securities fraud class action lawsuit has been filed against FibroGe...

1 week ago - Newsfile Corp

New York, New York--(Newsfile Corp. - April 28, 2021) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of FibroGen, Inc..Shareholders who ...

1 week ago - Newsfile Corp

Boston, Massachusetts--(Newsfile Corp. - April 28, 2021) - The Thornton Law Firm alerts investors that a class action lawsuit has been filed on behalf of investors of FibroGen, Inc. (NASDAQ: FGEN). The ...

1 week ago - Newsfile Corp

New York, New York--(Newsfile Corp. - April 28, 2021) - Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders FibroGen, Inc. (NASDAQ: FGEN).CLICK ...

1 week ago - Newsfile Corp

Los Angeles, California--(Newsfile Corp. - April 28, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against FibroGen, Inc. ("Fibr...

1 week ago - Newsfile Corp

New York, New York--(Newsfile Corp. - April 28, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased FibroGen, Inc. ("Fi...

1 week ago - Newsfile Corp

Boston, Massachusetts--(Newsfile Corp. - April 28, 2021) - Block & Leviton LLP (www.blockleviton.com), a national securities litigation firm, announces that a lawsuit for violations of the federal secur...

1 week ago - Newsfile Corp

SAN FRANCISCO, April 28, 2021 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) announced that Enrique Conterno, Chief Executive Officer, will participate in a fireside chat at the BofA Securities 2021 ...

1 week ago - GlobeNewsWire

New York, New York--(Newsfile Corp. - April 28, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of FibroGen, Inc. (NASDAQ: FGEN) alleging that...

1 week ago - Newsfile Corp

New York, New York--(Newsfile Corp. - April 27, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Fib...

1 week ago - Newsfile Corp

Los Angeles, California--(Newsfile Corp. - April 27, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against FibroGen, Inc. ("Fibr...

1 week ago - Newsfile Corp

NEW YORK, April 26, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of FibroGen, Inc. ("FibroGen" or the "Company")(NASDAQ: FGEN).  Such investors are advised to contac...

1 week ago - PRNewsWire

About FGEN

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases that is in Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States and Europe; and in Phase II/III development in China for anemia associated with myelodysplastic syndromes. It is also developing Pamrevlumab, a human monoclonal antibody that inh... [Read more...]

Industry
Biotechnology
IPO Date
Nov 14, 2014
CEO
Enrique Conterno
Employees
599
Stock Exchange
NASDAQ
Ticker Symbol
FGEN
Full Company Profile

Financial Performance

In 2020, FibroGen's revenue was $176.32 million, a decrease of -31.28% compared to the previous year's $256.58 million. Losses were -$189.29 million, 145.9% more than in 2019.

Financial Statements

Analyst Forecasts

According to 10 analysts, the average rating for FibroGen stock is "Buy." The 12-month stock price forecast is 40.57, which is an increase of 100.54% from the latest price.

Price Target
$40.57
(100.54% upside)
Analyst Consensus: Buy